Comparative outcomes of middle meningeal artery embolization, burr hole drainage, and neuroendoscopic-assisted evacuation with MMA disconnection for chronic subdural haematoma: a multicenter retrospective cohort study
- 1Department of Neurosurgery, Capital Medical University Affiliated Beijing Anzhen Hospital Nanchong Hospital
- 2Department of Neurosurgery, Guangyuan Central Hospital
Abstract
Objective: To compare the efficacy, safety, and resource utilization of middle meningeal artery embolization (MMAE), burr hole drainage (BHD), and neuroendoscopic-assisted evacuation with middle meningeal artery disconnection (NE-MMAD) for chronic subdural haematoma (CSDH).
Methods: A retrospective analysis was performed on 265 patients with CSDH, divided into MMAE ( n = 46), BHD ( n = 152), and NE-MMAD ( n = 67) groups. The primary outcome was the 6-month recurrence rate. Secondary outcomes included neurological improvement rate, reoperation rate, operation time, hospital stay, number of imaging follow-ups, and complications.
Results: The recurrence rates for MMAE and NE-MMAD (4.35 and 4.48%, respectively) were significantly lower than that for BHD (19.74%, p = 0.001). The neurological improvement rate was highest in the NE-MMAD group (88.06%, p = 0.003). The reoperation rates for MMAE and NE-MMAD were both lower than that for BHD ( p = 0.002). In the MMAE group, 5 patients (10.87%) underwent salvage BHD due to delayed resolution of mass effect. MMAE had the shortest operation time (31 min) and hospital stay (7 days), while NE-MMAD had the longest operation time (70 min); both MMAE and NE-MMAD required fewer imaging follow-ups than BHD (all p < 0.05). No significant difference in complication rates was observed among the three groups; however, one patient in the MMAE group experienced permanent blindness due to inadvertent embolization through a dangerous anastomosis.
Conclusion: In this cohort, MMAE and NE-MMAD were associated with lower recurrence compared with BHD, and NE-MMAD was associated with the greatest neurological improvement. BHD may be preferred for first-onset, non-septated haematomas; MMAE may be preferred for older patients or those with coagulopathy, but the risk of blindness warrants caution; NE-MMAD may be preferred for septated, organized, recurrent, and markedly space-occupying haematomas. Clinical decision-making should integrate haematoma characteristics, patient status, and available medical resources to guide individualized stratified treatment.
Related
- Real-world comparative outcomes of pyrotinib-based versus pertuzumab-based first-line therapy in HER2-Positive advanced breast cancer: a multicenter retrospective cohort study from Xinjiang, China
- Comparative Effectiveness and Safety of Etelcalcetide and Cinacalcet in Hemodialysis Patients with Secondary Hyperparathyroidism: A Multicenter Retrospective Cohort Study
- Comparative outcomes of timely versus delayed presentation of pediatric fractures in post-conflict Iraq: a multicenter retrospective cohort study
- Comparative effectiveness of total thyroidectomy versus hemithyroidectomy for low-risk differentiated thyroid cancer: a multicenter retrospective cohort study with propensity score matching.
- Development and Validation of Daping Orthopedics Operative Risk Scoring System for Geriatric Hip Fracture (DOORS‐GHF) for Predicting Postoperative Outcomes in Geriatric Hip Fracture Patients: A Multicenter Retrospective Comparative Study
BibTeX
@article{song2026comparative,
title = {{Comparative outcomes of middle meningeal artery embolization, burr hole drainage, and neuroendoscopic-assisted evacuation with MMA disconnection for chronic subdural haematoma: a multicenter retrospective cohort study}},
author = {Xudong Song and Yuan Zhang and Bo Luo and Xiyuan Tang},
journal = {Frontiers in Neurology},
year = {2026},
month = oct,
doi = {10.3389/fneur.2026.1975364},
url = {https://www.frontiersin.org/articles/10.3389/fneur.2026.1975364/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Comparative outcomes of middle meningeal artery embolization, burr hole drainage, and neuroendoscopic-assisted evacuation with MMA disconnection for chronic subdural haematoma: a multicenter retrospective cohort study
AU - Xudong Song
AU - Yuan Zhang
AU - Bo Luo
AU - Xiyuan Tang
PY - 2026
DA - 2026/10/19
JO - Frontiers in Neurology
DO - 10.3389/fneur.2026.1975364
UR - https://www.frontiersin.org/articles/10.3389/fneur.2026.1975364/full
AB - Objective: To compare the efficacy, safety, and resource utilization of middle meningeal artery embolization (MMAE), burr hole drainage (BHD), and neuroendoscopic-assisted evacuation with middle meningeal artery disconnection (NE-MMAD) for chronic subdural haematoma (CSDH). Methods: A retrospective analysis was performed on 265 patients with CSDH, divided into MMAE ( n = 46), BHD ( n = 152), and NE-MMAD ( n = 67) groups. The primary outcome was the 6-month recurrence rate. Secondary outcomes included neurological improvement rate, reoperation rate, operation time, hospital stay, number of imaging follow-ups, and complications. Results: The recurrence rates for MMAE and NE-MMAD (4.35 and 4.48%, respectively) were significantly lower than that for BHD (19.74%, p = 0.001). The neurological improvement rate was highest in the NE-MMAD group (88.06%, p = 0.003). The reoperation rates for MMAE and NE-MMAD were both lower than that for BHD ( p = 0.002). In the MMAE group, 5 patients (10.87%) underwent salvage BHD due to delayed resolution of mass effect. MMAE had the shortest operation time (31 min) and hospital stay (7 days), while NE-MMAD had the longest operation time (70 min); both MMAE and NE-MMAD required fewer imaging follow-ups than BHD (all p < 0.05). No significant difference in complication rates was observed among the three groups; however, one patient in the MMAE group experienced permanent blindness due to inadvertent embolization through a dangerous anastomosis. Conclusion: In this cohort, MMAE and NE-MMAD were associated with lower recurrence compared with BHD, and NE-MMAD was associated with the greatest neurological improvement. BHD may be preferred for first-onset, non-septated haematomas; MMAE may be preferred for older patients or those with coagulopathy, but the risk of blindness warrants caution; NE-MMAD may be preferred for septated, organized, recurrent, and markedly space-occupying haematomas. Clinical decision-making should integrate haematoma characteristics, patient status, and available medical resources to guide individualized stratified treatment.
SN - 1664-2295
ER -